Challenge to improve Japan's deplorable <scp>HPV</scp> vaccination rate by local government actions-Reference-Cited by-同舟云学术

Challenge to improve Japan's deplorable HPV vaccination rate by local government actions

Published:2022-03-10 Issue:5 Volume:48 Page:1233-1239
ISSN:1341-8076
Container-title:Journal of Obstetrics and Gynaecology Research
language:en
Short-container-title:J of Obstet and Gynaecol

Author:

Miyoshi Ai¹^ORCID,Ueda Yutaka¹^ORCID,Yagi Asami¹^ORCID,Kimura Toshihiro¹,Kobayashi Eiji¹^ORCID,Tasaka Keiichi²,Todo Aiko³,Matsunami Katsura³,Matsuoka Taro³,Kimura Tadashi¹

Affiliation:

1. Department of Obstetrics and Gynecology Osaka University Graduate School of Medicine Osaka Japan

2. Tasaka Clinic Osaka Japan

3. Toyonaka City Public Health Center Osaka Japan

Publisher

Wiley

Subject

Obstetrics and Gynecology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jog.15202

Reference16 articles.

1. Japan’s failure to vaccinate girls against human papillomavirus

2. Realistic fear of cervical cancer risk in Japan depending on birth year

3. HPV vaccination in Japan: what is happening in Japan?

4. HPV vaccination crisis in Japan

5. Potential for cervical cancer incidence and death resulting from Japan’s current policy of prolonged suspension of its governmental recommendation of the HPV vaccine

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human Papillomavirus Vaccination by Birth Fiscal Year in Japan;JAMA Network Open;2024-07-16

2. A questionnaire survey on the prevention of HPV infection among females and males who came of age in Japan under various scenarios of HPV vaccine recommendation;Human Vaccines & Immunotherapeutics;2023-07-18

3. Disparities among Japanese municipalities in recommendations for routine and catch‐up HPV vaccinations;Cancer Science;2023-02-28

4. Human papillomavirus: What we know and what we doing?;Archives of Community Medicine and Public Health;2023-02-03

5. The ‘best friend effect’: a promising tool to encourage HPV vaccination in Japan;International Journal of Clinical Oncology;2022-09-03